Skip to content

Adrenal Hyperplasia Congenital Due To 21 Hydroxylase Deficiency Late Onset Form C4017338

Published: July 22, 2026Updated: August 20, 2026

A genetic enzyme deficiency causing adrenal hyperplasia that appears later in life, often during adolescence or adulthood. Symptoms vary and are managed with hormone replacement therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Hirsutism

(integumentary)

Irregular menses

(reproductive)

Acne

(integumentary)

Clitoromegaly

(reproductive)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Low-Dose Glucocorticoid Replacement

Physiological glucocorticoid replacement using hydrocortisone or other suitable agents addresses cortisol deficiency while attempting to suppress excess androgen production characteristic of late-onset 21-hydroxylase deficiency.

medication
3

Metabolic and Hormonal Monitoring

Regular measurement of 17-hydroxyprogesterone, androgens, and electrolytes helps optimize treatment dosing and detect breakthrough androgen excess or under-replacement.

monitoring

Additional treatment options

Anti-Androgen Therapy

In females with hirsutism or acne, anti-androgen medications such as spironolactone may be added to block androgen effects at target tissues.

medication

Sodium Supplementation

Increased dietary sodium intake or supplemental salt may be recommended, particularly during hot weather or exercise, to help manage potential salt-wasting tendencies.

dietary

Psychological Support and Counseling

Counseling addresses body image concerns, fertility issues, and the psychological impact of managing a chronic hormonal condition. Support groups connecting patients with similar conditions provide valuable peer support.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Adrenal Hyperplasia Congenital Due To 21 Hydroxylase Deficiency Late Onset Form C4017338?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018.

guideline2018
2

Turcu AF, Nanba AT, Auchus RJ. The contribution of adrenal androgens to the hormonal phenotype of nonclassic congenital adrenal hyperplasia. Endocrinol Metab Clin North Am. 2021.

review2021
3

Mendoza-Caamal EC, González-Huerta LM, Rivera-Vega MR, et al. Low-dose dexamethasone suppression test in the diagnosis of late-onset 21-hydroxylase deficiency: a pilot study. J Pediatr Endocrinol Metab. 2020.

clinical_trial2020
4

Krone N, Rose IT, Willis DS, et al. Genotype-phenotype correlation in 297 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a meta-analysis. Eur J Endocrinol. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Adrenal Hyperplasia Congenital Due To 21 Hydroxylase Deficiency Late Onset Form C4017338. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy